Furthermore, PD-L1 regulated CSCs features in colorectal cancer [25], breast cancer [33] and pancreatic cancer [44], and this study validated that low-dose DB negatively regulated PD-L1 to inhibit cell stemness in CR-GC cells. The gene discussed is CD274; the disease is breast carcinoma.